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Tamaka Shwasa is one among the major disease explained in Ayurveda is 
caused due to vitiation of Kapha and Vata dosha in Pranavaha srotas. The 
condition is analogous to bronchial asthma as explained in modern 
medical science. India has an estimated 15-20 million Asthmatics every 
year and the disease occurs at very young age that survey states one in 
every six child under the age of 16 is affected. 
Asthma is characterized by recurrent attacks of breathlessness and 
wheezing which vary in severity and from person to person. It is a chronic 
condition, which frequently requires continuous medical care, comprising 
of different routes of administration and the important one is the 
inhalation route which has been developed to administer the drugs by 
delivering to site of action and to get immediate effects. Most of our 
Acharyas have explained different treatment modalities in the 
management of Tamaka Shwasa that consists of Shodhana, Shamana and 
Tarpana, but the concept of ‘Arka prayoga’ is explained in Arka Prakasha 
which stands unique. The book written by Ravana has explained different 
drugs used to prepare Arka (Extraction of active principles through the 
distillation process), its preparation method, qualities and application of 
Arka on different diseases internally as Pana along with its dosage in 
detail. In the study during the attack of Shwasa one group was 
administered Ardraka arka pana and the second group was administered 
Dhumapana (inhalation) with Ardraka arka by Nebulization method to 
conceptualize the study and parallel new perspective to rising trend in 
management of asthma in exacerbated condition. Statistical significance of 
selected criteria showed highly significant results in Dhumapana 
(Nebulization) by proving that natural therapies like Ayurveda can 
provide a better direction in improving the quality of life of Shwasa 
patients without any adverse effects of medications. 
 
INTRODUCTION 
Tamaka Shwasa, one among the five varieties 
of Shwasa happens due to vitiation of Kapha and Vata 
dosha with the involvement of Rasadi dhatus in 
Pranavaha Srotas. It is a Yapya vyadhi (Palliative) 
which becomes Asadhya (incurable) when it reaches 
to chronicity more than a year. Here the vitiated 
Kapha in Pranavaha srotas obstructs Vata to produce 
Shwasa lakshanas1. The condition like “Shwasane 
Krichra Jeevane” refers to increased respiration with a 
great distress, where the life is at risk. Tamaka 
Shwasa in severe condition is life threatening and 
needs emergency supportive measures, and an 
identical view is been given in Charaka Samhita in 
Hikka Shwasa adhyaya as an Atyayika condition 
(emergency condition). Among many clinical features 
explained in Tamaka Shwasa it can be inferred that 
only few symptoms like Shwasa krichrata (difficulty 
in breathing), Kasa (cough), Gurguraka (Wheezing) 
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Pradhana lakshana can be considered as Prathyatma 
lakshana (Cardinal features) because these four 
symptoms are the direct manifestation of the 
pathological process.  
Asthma is a chronic inflammatory disorder of 
airway characterized by a reversible airflow 
obstruction causing cough, wheeze, chest tightness 
and shortness of breath, which vary in severity and 
frequency from person to person. In an individual, 
they may occur from hour to hour and day to day.2 
Several stimuli trigger airway narrowing, wheezing 
and dyspnoea in Asthmatic patients. While the 
previous view held that these should be avoided, it is 
now seen as evidence for poor control and an 
indicator of the need to increase controller 
(preventive) therapy. 
Asthma is one of the most common chronic 
diseases globally and currently affects approximately 
300 million people worldwide. In developing 
countries where the prevalence of Asthma had been 
much lower, there is a rising prevalence, which is 
associated with increased urbanization. The 
prevalence of atopic and other allergic diseases has 
also increased over the same time, suggesting that the 
reasons for the increase are likely to be systemic 
rather than confined to the lungs.  
Table 1: Showing the risk factors involved in 
bronchial asthma3 




Exercise and hyperventilation 
Whether change and cold air 
Tobacco smoke 
Frequent exposure to environmental factors 
or else repeated attacks of Tamaka Shwasa tends to 
weaken the Pranavaha Srotas there by worsening the 
situation. Chronic and recurrent occurrence of 
disease determines the poor prognosis of the Tamaka 
Shwasa in Ayurveda.  
Regard to the management of this condition 
Shodhana, Shamana, Nidana parivarjana plays a 
major role in Samprapthi vighatana of the disease 
thereby balancing the Doshas involved. As the Vata 
and Kapha are the important Dosha and being 
Amashayotha vyadhi, Shodana is the best treatment 
by means of Vamana and Virechana.  
The drugs used in conventional system are 
Anti inflammatory agent, long acting bronco dilators, 
antileukotrines, short acting medicines like Beta2 
agonists, anti cholinergic, phospho diesterase 
inhibition, glucocorticoids and anti-microbial which 
also has adverse effects like dry or irritated throat, 
sneezing, stuffy or itchy nose, watery eyes, nose 
bleed, nausea, frequent urination, dizziness, 
drowsiness, headache, skin rash, bruising, severe 
tingling, numbness, pain, muscle weakness, joint pain 
and general illness.  
In Arka Prakasha the author has explained 
intake of Ardraka Arka and its benefits in tackling the 
signs and symptoms of Asthma. In the prevailing 
situations the inhalation routes developed so far is 
the unsurpassed method to reduce the undesirable 
effects of systematic administration. In Ayurvedic 
literature, the inhalation of medicated Dhooma is 
called Dhoomapana and the procedure was advised in 
managing Shwasa particularly when Alpadosha is 
present in an episode. Thus keeping the importance 
of Nebulization in managing Tamaka Shwasa the 
classic preparation was conceptualized with certain 
modifications for convenience and which was also 
economical was taken up in one group and advised 
Ardraka arka Nebulization, whereas internal 
administration of Ardraka arka was advised in second 
group during the episodic attack of Shwasa.  
AIMS AND OBJECTIVES  
1. To evaluate the efficacy of Ardraka arka Pana 
in the management of Tamaka Shwasa.  
2. To conceptualize Ardraka Arka for the purpose 
of Dhoomapana by inhalation method with 
certain modification and convenient 
administration. 
3. To assess the therapeutic effect of Arka 
Dhoomapana in the form of nebulization in 
Tamaka Shwasa. 
4. To compare the above two groups and 
ascertain the added effect of inhalation of 
aqueous extract of Ardraka (root) through 
nebulizer in Tamaka Shwasa. 
MATERIALS AND METHODS  
Source of data 
Patient of Tamaka Shwasa attending the 
Outpatient Department of SKAMCH & RC, Bangalore 
was selected for the present study after the clearance 
from ethical committee of the institution. Written 
consent was taken from each patient willing to 
participate prior to the study and patients were free 
to withdraw from the study at any time without 
giving for any reason thereof.  
Diagnostic criteria 
Patient presenting with signs and symptoms 
of Tamaka Shwasa (Bronchial Asthma). The 
parameters with complaints of difficulty in breathing, 
wheeze, cough, expectoration (Sputum) and variation 
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Table 2: Showing the inclusion criteria and exclusion criteria for bronchial asthma 
INCLUSION CRITERIA EXCLUSION CRITERIA 
 Patients of either sex between 10 to 70 years. 
 Patient presenting with Lakshanas of Tamaka 
Shwasa (Bronchial asthma). 
 Other systemic disorders which interfere with the 
course of treatment. 
 Asthma associated with any upper respiratory or 
lower respiratory tract infection. 
ABOUT THE MEDICAMENT 
In Arka Prakasha, while explaining different 
types of Arka preparations author mentions that 
Ardraka Arka is beneficial for Tamaka Shwasa 
because of its Kapha Vatahara and Ushna properties.4  
DRUG - ARDRAKA  
Latin Name: Zingiber Officinale  
Family: Zingeberaceae 
Synonyms: Vishwa, Nagara, Vishwabheshaja, Ushana, 
Katubhadra, Shringavera, Mahoushadha.  
Rasa panchaka 
Rasa: Katu, Guna: Laghu. Veerya: Ushna. Vipaka: 
Madhura  
Doshaghnata: Kaphavatahara. Rogaghnata: 
Swarabheda, Vamana, Swasa, Shoola, Kasa, Hridroga, 
Shoola, Shleepada,Arshas Udara, Anaha. 
Chemical composition: Out of all the chemical 
constituents Gingerol, Zingrberenes, Zingeberol, 
Shogaol, isoproterenol, Essential oils are those which 
act on respiratory system. 
PREPARATION OF ARKA 
One part of fresh Ardraka was cleaned with 
water and smashed. Then it was transferred into a 
distillation apparatus with attached condenser. 
Twenty parts of water was added and the apparatus 
was closed securely. The apparatus was heated for 1 
Muhurta (48 minutes) and then the Arka was 
collected which was draining out of the receiver after 
leaving first 5 to 7 drops. Then the Arka was collected 
till water is reduced to 50% of total water taken. The 
collected Arka was stored in an air tight glass bottle.5 
Inhalation principles 
Inhalation of chemicals prevents the most 
rapid and direct avenue of entry because of the 
intimate association of air passage in the lung with 
the circulatory system. When a foreign agent is 
inhaled it may be deposited in the respiratory tract 
and subsequently absorbed, exhaled or neutralized by 
the lungs defense. They are intended for 
administration to the lower respiratory tract for local 
or systemic effect by adversely affecting the functions 
of the mucosa of the respiratory tract and its cilia. The 
preparations are supplied in multi dose or single-
dose containers provided with a suitable 
administration device. Two categories of 
preparations for inhalation may be distinguished: 
liquid and solid preparations like powders, tablets, 
capsules that consist of one more active ingredient. 
These preparations are converted into an aerosol and 
are generally administered by nebulizers, by 
pressurized metered dose inhalers or by dry-powder 
inhalers.6 
Particle size and ph 
In inhalation liquid if the size and shape of 
particle, is less than 5 micron mili diameter it can 
affect their solubility (May and Kolthoff 1948). As 
particle size decreases the solubility will increase. 
The pH of the liquid used for inhalation should not be 
lower than 3. If a liquid is provided in concentrated 
form, it should be diluted in the nebulizer to the 
prescribed volume before use.7 
The prepared Arka for the study was tested 
in Bangalore Test House for particle pointer and pH. 
The particle size in the prepared Arka was 5 micron 
mili diameter and pH was 5.  
STUDY DESIGN 
The study followed Randomized open case 
study of 10 subjects who satisfied the study criteria 
and were divided into two groups with 5 in each 
group, Group A (study group) and Group B (control 
group). The patients of Group A was treated with 5ml 
of Ardraka Arka nebulization and patients of Group B 
was given one Pala (48ml) of Ardraka Arka internally 
in single dose. 
Criteria for Assessment: The assessment was done 
on improvement in signs & symptoms before 
treatment and 20 minutes after treatment in Group A 
and 40 minutes after treatment in Group B with the 
help of suitable scoring method ranging from 0 - 3. 
The subjective & objective parameters considered are 
Table 3: Showing the subjective parameters and 
objective parameters for bronchial asthma. 
Subjective Parameters Objective parameters 
 Wheeze 
 Sputum 
 Respiratory rate 
 Heart rate 
 Ronchi 
 Peak expiratory flow 
Statistical analysis: The data obtained before and 
after the treatment were subjected for statistical 
analysis in terms of mean score, standard deviation 
(SD), and standard error (SE) and by applying paired 
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OBSERVATIONS AND RESULTS 
Table 4: Showing the sex wise distribution of bronchial asthma 
Variables Group A  Group B  
Number % Number % 
GENDER 
Male 1 20% 3 60% 
Female 4 80% 2 40% 
Total No. of patients 5 100% 5 100% 
Table 5: Showing the age wise distribution of bronchial asthma 
Variables Group A  Group B  
Number % Number % 
AGE IN YEARS 
21-30 1 20% 0 00% 
31-40 0 00% 1 20% 
41-50 2 40% 1 20% 
51-60 1 20% 2 40% 
61-70 1 20% 1 20% 
Total No. of patients 5 100% 5 100% 
Table 6: Showing the education wise distribution of bronchial asthma 
Variables Group A  Group B  
Number % Number % 
EDUCATION 
Illiterate 1 20% 1 20% 
School/PUC 3  3  
Graduates 1 20% 0 00% 
Post- Graduates 0  1 20% 
Total No. of patients 5 100% 5 100% 
Table 7: Showing the socio-economic distribution of bronchial asthma 
Variables Group A  Group B  
Number % Number % 
SOCIO-ECONOMIC STATUS 
Poor 1 20% 3 60% 
Middle class 3 60% 1 20% 
Upper middle class 1 20% 1 20% 
Rich 0 00% 0 00% 
Total No of patients 5 100% 5 100% 
Table 8: Showing the family history of bronchial asthma 
     Table 9: Showing the pattern of changes in clinical features before and after the treatment in group-A 
Parameters X of diff. % relief SD SE ‘t’ P Value Results 
Wheeze 2.4 98% 0.54772 0.24561 9.77 <0.001 HS 
Sputum 1.2 62% 0.44721 0.20054 5.98384 <0.01 HS 
Respiratory Rate 1.6 77% 0.54772 0.24561 6.5143 <0.001 HS 
Heart Rate 1.4 70% 0.54772 0.24561 5.70009 <0.01 HS 
Ronchi 1 56.7% 1.41 0.37 2.74 <0.05 S 
PEF(Person’s Best) 1.6 63.6% 0.54772 0.24561 6.5143 <0.01 HS 
Variables Group A  Group B  
 Number % Number % 
FAMILY HISTORY 
Present 2 40% 1 20% 
Absent 3 60% 4 80% 
Total No. of Patients 5 100% 5 100% 
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Group A showed highly significant results with p value (p<0.001) in wheeze, respiratory rate, highly significant 
results with p value (p<0.01) in PEF, heart rate and Sputum whereas significant results (p<0.05) in ronchi. 
Table 10: Showing the pattern of changes in clinical features before and after the treatment in group-B. 
PARAMETERS X % relief SD SE ‘t’ P Value Results 
Wheeze 1.6 63.66% 0.54772 0.24561 6.5143 p< 0.01 HS 
Sputum 1 56.7% 1.41 0.37 2.74 p>0.05 HS 
Respiratory Rate 1 56.7% 1.41 0.37 2.74 p<0.05 HS 
Heart Rate 1.6 63.66% 0.54772 0.24561 6.5143 p< 0.01 HS 
Ronchi 1 56.7% 1.41 0.37 2.74 p>0.05 IS 
PEF(Person’s Best) 1 56.7% 1.41 0.37 2.74 p<0.05 S 
 In Group B, improvement in wheeze, heart 
rate was observed with highly significant results with 
p value (p< 0.01), decrease in respiratory rate, PEF 
was seen with significant results with p value 
(p<0.05) and showed insignificant with p value 
(p>0.05) in ronchi and sputum. 
On concluding statistically Group A has shown 
considerable result in reducing the symptoms when 
compared to Group B with p values (p<0.001 & 
p<0.01) 
MODE OF ACTION 
Ardraka (Zingiber Officinale) mainly acts on 
Tamaka Shwasa by its Vatakaphahara and Ushna 
Veerya properties. Its Bhedana karma mainly helps in 
Kapha Bhedana and helps in clearing Marga avarana 
caused by Kapha during an episode by providing easy 
movement of Vayu. The essential oil of Ardraka which 
has Gingerol and when dried or cooked it is 
converted into Shogaol and Zingerone. These 
components are found to have anti tussive, anti 
inflammatory, anti bacterial, anti histaminic and anti 
histamine action and also have potent inhibitory 
effect on prostaglandin synthesis. The anti 
inflammatory activity helps in reducing the 
inflammation & edema of the mucous membrane, 
lining the airway. 
 The anti tussive property helps to liquefy and 
drain the mucous plugged in airways causing 
obstruction, which has secreted from 
inflammatory cells thereby clearing the airway by 
providing respiration at ease and reducing the 
cough. 
 The antihistamine property helps in inhibition of 
the mast cells thereby by stabilizing the release of 
chemical mediators like histamine, serotonin, 
leukotrienes. 
 The inhibitory activity of the prostaglandin 
biosynthesis regulates the contraction and 
relaxation of smooth muscles of lungs thus helps 
in reducing the bronchospasm and inflammation. 
As these prostaglandins are synthesized by mast 
cells and basophils they also help in their 
inhibition and thereby reducing the 
inflammatory reaction. 
 The antioxidants property reduces body 
inflammation in general and helps to identify and 
nullify the disease causing free radicals. 
DISCUSSION 
Tamka Shwasa is explained since classical 
age of Ayurveda by both greater and lesser trials. It is 
closely correlates with Asthma. Shwasa Krichrita, 
Kasa, Gurguraka are the Pradhana laxana of Tamaka 
Shwasa with a variation in PEFR. Classical texts 
clearly mentions the occurrence of Tamaka Shwasa in 
Tama or durdina that means cloudy / darkness which 
refers to night hours. Multiple cause approach is 
encouraged by the fact that this Grosodic disorder 
itself is defined a multi factorial disease with a large 
series of causative, inducing, triggering and 
aggravating factor. 
 The Samprapthi is also complex as the role 
of Nidana agnimandya, Ama, Khavaigunya is very 
important in its process. Vata initiates while the 
Kapha drives the illness along with hyper secretion of 
Kapha to produce obstruction in Pranavaha srotas 
and is responsible for its clinical manifestation. The 
Chikitsa of Shwasa mainly bifurcated under two 
headings. 
 Kapha adhika, Balasta is to be managed by 
Vamana followed by Virechana, Patya, 
Dhumapana, Lehyadi shamana Oushadies.  
 Vatadikya, durbala such as Baala, Vrudda are to 
be treated with Tarpana and Shaman Chikitasa 
which includes Sneha Yusha.8 
Acharya Chakarapani’s statement- Tamaka 
Shwasa can be treated with Dhoomapana alone 
without Vamana if a condition is arising out of Swalpa 
dosha and further line of treatment includes the 
advice of Oushadhies or Ahara or Pana which have 
Kapha Vataghna and Ushna property can be 
substantiated here as in these days diagnosed 
patients of Bronchial Asthma, experiencing mild 
symptoms on exposure to various triggering factors 
like Rajo, Dhuma, Vata sevana, residing in Sheeta 
stana, Sheeta jala sevana, Ati vyayama when approach 
any physician, can be administered with Dhoomapana 
for instantaneous effect.  
Bronchial Asthma is a condition 
characterized by generalized but reversible bronchial 
airway obstruction. Patient present with dyspnoea 
and wheezing due to increased resistance for the 
passages of exhaled air. The main aim is to give relief 
to the patient from the attack/exacerbation and then 
to be maintained to arrest the frequency of attacks.  
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Also there is a specific instruction given in 
the same chapter 148th quotation the drugs which 
alleviates Kapha but aggravates Vayu and vice versa 
should never be used along with this Chakrapani 
quotes Kapha Vataghna chikitsa is Pradhana chikitsa. 
In this context the drug Ardraka holds the properties 
to balance these Doshas and it is a very easily 
available drug everywhere throughout the year 
having the property Kapha Vataghna, Ushna thus this 
drug was selected.  
Ginger contains a number of pungent 
constituents and active ingredients. Steam distillation 
of powdered ginger produces ginger oil, which 
contains a high proportion of sesquiterpene 
hydrocarbons, predominantly zingiberene. The major 
pungent compounds in ginger, from studies of the 
lipophilic rhizome extracts, have yielded potentially 
active gingerols, which can be converted to shogaols, 
zingerone, and paradol. These compounds appear to 
be responsible for its beneficial action in bronchial 
asthma when administered through inhalation or oral 
route. Nebulization is a method which is very popular 
these days to manage mild symptoms of Tamaka 
Shwasa with certain modifications and Dhoomapana 
can be administered as Nebulization. There by 
Ardraka Arka which has the Kapha Vataghna and 
Ushna properties and Dhoomapana which is advised 
to be given in Swalpa dosha without Vamana can be 
best alternative method for the management of 
Tamaka Shwasa. 
CONCLUSION 
Tamaka Shwasa can attain acute condition 
any time during the course of illness. In 69th shloka of 
Shwasa and Hikka chikitsa adhyaya of Charaka 
Samhita it suggest if immediate measures is not 
instituted it is ‘Pranahara’ (fatal). Hence, Atyayiki 
chikitsa i.e., emergency and supportive treatment 
should be instituted. Thus the improvised method of 
Dhoomapana like inhalation of the drugs which 
would act on the target organ, the lung directly to the 
need of hour is established here.  
The volatiles oils when administered orally 
or inhaled with steam increase the respiratory 
secretions probably by direct stimulation. They act 
like expectorant which help in production of 
demulcent respiratory tract fluid that covers and 
protects the mucosa. They liquefy by increasing the 
secretions, expel out and relax the irritated mucosa. 
When these constituents are distillated the vapors 
collected and condensed will be more concentrated. 
Dhoomapana is one of the procedure performed 
particularly when Alpa dosha is present and also for 
Shodhana anarha patients, as told in the classics. The 
procedure can dispense the drug directly into the 
target organ through inhalation. Use of inhalation of 
Ardraka extract through nebulizer in mild to 
moderate condition is of utmost benefit to the 
patient, as it reduces the chest tightness along with 
good expectoration and a reduction the intensity of 
ronchi. Based on the references a single drug Ardraka 
has good broncho dilatation effect as outcome of 
inhalation was found less than 20 minutes in 
reduction of symptoms and increase of PEFR whereas 
the changes were seen after 40 minutes when Arka 
was administered internally. 
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